D. Gray Heppner - Concepedia

Author

D. Gray Heppner

Also Known As

D G Heppner, D Gray Heppner, D Heppner, D. G. Heppner, D. GRAY HEPPNER, D. Gray Heppner, D. Gray Heppner Jr, D.G Heppner, D.G. Heppner, D.Gray Heppner

102

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research GlaxoSmithKline (Belgium)Armed Forces Research Institute of Medical Science GlaxoSmithKline (United Kingdom)United States Agency for International Development

About

D. Gray Heppner is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and malaria.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	44	3.8K
2	Allergy	4	4	238
3	Health Sciences	2	2	98
4	Natural Sciences	2	2	94
5	Public Health	2	2	309

D. Gray Heppner

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against<i>Plasmodium falciparum</i><i>Malaria</i> José A. Stoute, M. Slaoui, D. Gray Heppner, New England Journal of Medicine	1997	874
Protection of Humans against Malaria by Immunization with Radiation‐Attenuated<i>Plasmodium falciparum</i>Sporozoites Stephen L. Hoffman, Lucy M. L. Goh, Thomas Luke, The Journal of Infectious Diseases	2002	686
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Samuel McConkey, William H. H. Reece, Vasee Moorthy, Nature Medicine VaccinationVaccine DevelopmentImmunologyPlasmid Dna VaccinesTherapeutic Vaccine	2003	557
Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam, The Journal of Infectious Diseases	2009	533
A Field Trial to Assess a Blood-Stage Malaria Vaccine Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly, New England Journal of Medicine	2011	358
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya Bernhards Ogutu, Odika J. Apollo, Denise McKinney, PLoS ONE	2009	341
Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit Vaccine Daniel M. Gordon, Thomas W. McGovern, Urszula Krzych, The Journal of Infectious Diseases VaccinationVaccinologyVaccine DevelopmentMalaria-naive VolunteersVaccine Target	1995	325
Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental<i>Plasmodium falciparum</i>Malaria Kent E. Kester, Denise McKinney, Nadia Tornieporth, The Journal of Infectious Diseases	2001	270
Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway Sathit Pichyangkul, Kosol Yongvanitchit, Utaiwan Kum-Arb, The Journal of Immunology	2004	265
Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to <i>Plasmodium falciparum</i> Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ Peifang Sun, Robert Schwenk, Katherine White, The Journal of Immunology	2003	231

Page 1